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We employ a multi-scale mechanistic approach built upon our recent phenomenological / compu-
tational methodologies (Ref. [42]) to investigate radiation induced cell toxicities and deactivation
mechanisms as a function of linear energy transfer in hadron therapy. Our theoretical model con-
sists of a system of Markov chains in microscopic and macroscopic spatio-temporal landscapes,
i.e., stochastic birth-death processes of cells in millimeter-scale colonies that incorporates a coarse-
grained driving force to account for microscopic radiation induced damage. The coupling, hence
the driving force in this process, stems from a nano-meter scale radiation induced DNA damage
that incorporates the enzymatic end-joining repair and mis-repair mechanisms. We use this model
for global fitting of the high-throughput and high accuracy clonogenic cell-survival data acquired
under exposure of the therapeutic scanned proton beams, the experimental design that considers γ-
H2AX as the biological endpoint and exhibits maximum observed achievable dose and LET, beyond
which the majority of the cells undergo collective biological deactivation processes. An estimate
to optimal dose and LET calculated from tumor control probability by extension to 106 cells per
mm-size voxels is presented. We attribute the increase in degree of complexity in chromosome
aberration to variabilities in the observed biological responses as the beam linear energy transfer
(LET) increases, and verify consistency of the predicted cell death probability with the in-vitro cell
survival assay of approximately 100 non-small cell lung cancer (NSCLC) cells. The present model
provides an interesting interpretation to variabilities in α and β indices via perturbative expansion
of the cell survival fraction (SF) in terms of specific and lineal energies, z and y, corresponding
to continuous transitions in pair-wise to ternary, quaternary and more complex recombination of
broken chromosomes from the entrance to the end of the range of proton beam.
PACS numbers:
I. INTRODUCTION
The Bragg peak and capability in delivering a sharp
dose deposition pattern in deep-seated cancerous / ma-
lignant tumors is the main advantage of using protons
and Heavy ions in radiation therapy [1–4]. However, a
complete and robust model that describes the cellular
response and the biological effectiveness of the charged
particle along the track of radiation beam is still lacking.
In particular, uncertainties in the biological data at lo-
cations distal to the Bragg-peak (just beyond the Bragg
peak, i.e., in the tail region) where the charged particle
stopping power diverges are the main challenge for the bi-
ological dose calculation in treatment planning systems.
Thus, open questions on the biological effect of particles,
which is often expressed in terms of relative biological ef-
fectiveness to photons [5] (RBE), are yet to be answered.
It is known that generated ions and electrons (prod-
ucts of ionizations and not e.g. recoil nuclei) along the
path of a particle track crossing a DNA material can
potentially induce double strand breaks (DSBs) [1,3,4].
The DNA damage and the subsequent biochemical path-
ways [6] induced by ionization and non-ionizing (meV )
molecular excitations, including thermal conduction and
shock waves were recently investigated [7–11].
The DSBs are fundamental elements in causing lethal
damages to cells and their mitotic / meiotic offsprings.
Following DSB formation, enzymatic repair processes
trigger chromosomes end-joining, either through homol-
ogous or non-homologous pathways, depending upon the
cell type and cell cycle. This process determines the
particle RBE and is error-prone meaning that there are
possibilities in mis-joining chromosomes that may yield
apoptotic or necrotic cell death [1] and may increase the
risks of second malignancies [12]. In general, RBE de-
pends on the fractionation scheme, biological endpoint,
radiation quality, the tissue and cell-type.
Recently a graded solid water compensator was de-
signed to allow irradiation of cells by mono-energetic
scanning beam of protons at specific depths [13]. Sub-
sequent high-throughput automated clonogenic survival
assays were performed on non-small cell lung cancer
(NSCLC) cells to spatially map the biologic effectiveness
of scanned proton beams with high accuracy.
This method reduces uncertainties in biological data.
However, the current RBE models [14–36] including the
microdosimetric kinetic model (MKM) [19–21], local ef-
fect model (LEM) [22–26], Wilkens and Oelfke [27], Ste-
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2instra¨ter et al. [33], and Monte Carlo damage simulation
(MCDS-RMF) [34–36], do not adequately explain these
data. In particular, these models underestimate the in-
crease in radiobiological response functions, i.e., linear-
quadratic (LQ) α and β indices, in addition to RBE in
locations beyond the Bragg-peak.
Fitting of several existing methods to the experimental
data has recently investigated and presented in Ref.[37].
Accordingly, these models are not capable of explaining
the high non-linearity of RBE that was observed in pre-
clinical studies at higher LET at points beyond the Bragg
peak. An increased complexity in double strand breaks,
that is the focus of the present work, was suggested to
attribute to the experimentally observed non-linearity at
higher LETs.
Recently a microscopic computational study based on
interfacing Monte Carlo track structure calculation and
DNA molecular dynamics (MD) [6,38,39], predicted the
increase in relative DSBs induction of protons up to a
factor of 4 compare to a beam of radiation with LET
of unity. This is consistent with the RBE measurement,
reported by Guan et al. [13]. In addition, effects of low-
energy protons and ions have been simulated in detail
recently by Friedland et al. [40] and Meylan et al. [41].
The predicted enhancements in yields of DSB and DNA
fragments with increasing LET is qualitatively compara-
ble to the quoted number and data in Ref. [13].
Recently a computational model for relative biologi-
cal effectiveness of therapeutic proton beams based on a
global fit of cell survival data has been introduced by our
group in Ref. [42]where a numerical approach in fitting
a surface to survival fraction (SF) experimental data in
a three-dimensional parameter space using two indepen-
dent variables, dose and linear energy transfer (LET),
has been implemented. This approach allows achieving
a smooth relation between cell survival and LET for the
entire range, of LET up to the end of the beam range
where LET grows non-linearly before it vanishes. The
improvement in the numerical stability of the extracted
RBE data has revealed the superiority against the tra-
ditional fitting approaches [1] where the fitting is per-
formed for each individual survival curve with a specific
average LET. We carried out an iterative global fit to
the measured data and calculated RBE self-consistently
and showed that the process reduces the overall uncer-
tainty. The results in fitting SF’s for two separate cell
lines, H460, and H1437 show a non-linear increase in
RBE in domains distal to the Bragg peak. Simultane-
ous fits of SF data in dependence on the dose and LET
which have been examined and presented by Kundrat et
al. [45,46].
In spite of reliability and success in numerical results,
it would be challenging to quantitatively identify the bio-
physical processes throughout the fitting data. Particu-
larly in practical approaches, the LET dependence of cell-
survival data may vary among different fitting procedures
in a range of the beam where experimental uncertainties
are significant, i.e., by the end of the proton range, distal
to Bragg peak, where measuring the dose deposition and
identifying the accurate value of LET are challenging.
To address these issues, we developed an analytical
analogue and present a theoretical approach and math-
ematical details of the fitting model. In particular we
present a detail description in the relative biological effec-
tiveness of proton beams as a function of their LET. The
model aims at capturing the stochastic nature of energy
deposition as well as complex patterns of chromosome
aberrations. The present model relies on microdosimetry
and its formalism, a model formulated based on general-
ization of MKM. Event-by-event track structure simula-
tions as described by Nikjoo et al. [43] and Friedland et
al. [44] were performed to capture the energy deposition
and subsequent processes in greater detail.
In addition to the initial damage clustering, the chro-
matin dynamics and the resulting mobility of induced
intra- and inter-chromatin ends have been incorporated
in our model through phenomenological repair and mis-
repair rate equations. The latter accounts for the ex-
change of chromosome fragments and rejoining of dif-
ferent chromosome ends among each other. Numerous
studies on aberration formation have estimated that only
breaks within about 1 micrometer may misrejoin and
form aberrations (e.g., see for example Refs. [47,48].
Track structure-based simulations have been extended to
DSB repair and formation of chromosome aberrations.
Both temporal and spatial effects have been represented
via interplay of enzymatic processing of DNA termini and
their mobility (e.g., see for example Refs. [49,50]).
The present model predicts interesting phenomenon,
i.e., occurrence of continuous transitions in population
of chromosome aberration complexes amongst binary,
ternary, quaternary and higher order combinations as
LET of scanned beam varies continuously. The predic-
tions and mathematical hypothesis of evolution of chro-
mosome complexities as a function of LET has not been
verified experimentally. However, we propose a system-
atic experiment to be performed to investigate the com-
plexity of chromosome aberration as a function of particle
LET. Such measurement can be fine-tuned to perform bi-
ological spectroscopy of the beam energy loss and to be
considered as a signature of particle RBE.
We devote last sections to present calculation of the
lethal lesions and tumor control probability (TCP) as a
function of dose and LET for non-small cell lung can-
cer (NSCLC), H460 and H1437. The framework of our
computational platform is based on generalized MKM
and a multi-scale three-dimensional global fitting [42] of
the cell survival, recently measured by our experimen-
tal group in MD Anderson [13]. Our methodology is
consistent with other methodologies for proton and ion
beam therapy, based on a multiscale framework that have
been developed and applied successfully to describe cel-
lular response and RBE for ion irradiation (see for exam-
ple Ref. [8,9] and references therein). We further verify
matching of the cell death probability calculated specifi-
cally for the in-vitro cell survival assay with a maximum
3achievable dose and LET observed in the experiment,
beyond which the majority of the cells exhibit biologi-
cal deactivation. We finally summarize our work with
discussion and conclusion.
II. MATERIALS AND METHODS
A. Basic definitions and model calculation
Before going through the details and mathematical
construction of the present model, we first clarify the
definition of “event” consistent with the collective phe-
nomenon and formulation of DSBs developed in this
work, and non-Poissonian distribution of ionizations
based on Kellerer-Rossi’s theory of dual radiation ac-
tion [52]. In this context, “an event” refers to a series of
energy depositions in ionization processes induced from
passage of “a primary charged particle”, hence an event
refers to all spatiotemporal energy-depositions induced
by passage of a single proton through a volume of inter-
est, e.g., a cell nucleus.
Occurrence of an individual ionization takes place
within an electrodynamic time scale (10−18-10−17 s), and
in subatomic length scales. The time and length scales
are fundamental / natural scales relevant to the atom-
istic excitations. Traversing a primary charged particle
through a medium creates a collection of spatially scat-
tered ionizations and release of secondary charge parti-
cles, all can be mapped into a particle’s entity, known as
a single particle track structure. Hence we refer a single-
event scored in DNA material to a single track structure
generated from passage of a primary charged particle.
Out of large number of energy deposition processes
along a single track, few nm-scale DSBs form in DNA
materials in nm-size target volumes. This number de-
pends on the size of ionization clusters and the energy
balance requirement needed for induction of DSBs. Fig-
ures 1 and 2 schematically illustrates this process.
Scoring the processes that initially yield DNA hy-
drogen abstraction, and by several orders of magnitude
elapses to DSB formation, cell lethality and tissue toxi-
cities, requires modeling in multi-scale landscapes. Al-
though the basis of multi-scaling in our approach is
conceptually consistent with similar studies recently re-
ported in the literature, (e.g., see Ref.[8–10]), but there
are differences that require to be clarified.
Our computational steps begin with simulation of the
initial physical and chemical DNA damage processes in
atomic scale, as shown in Figure 1. In this step, we first
score energy and coordinates of all types of molecular ex-
citations, in addition to atomic ionizations using Geant4-
DNA [58]. Because of significant difference in time scales
between the direct energy transfers to water molecules
surrounding DNA and indirect energy transfers to DNA
via chemical reactions and free radicals, in the second
step of computation, the ionization coordinates, energy
transfers to medium, stepping length of each interaction,
the distance the particle travels before losing energy by
interaction, and other useful information obtained from
Geant4-DNA, will be cast into a look-up table to be used
as initial conditions to a ReaxFF MD, a quantum me-
chanical model appropriate for simulation of chemical re-
actions. The ReaxFF MD simulation box / voxel consists
of a double-strand DNA molecule, water molecules that
form an aqueous environment in addition to free radicals
that invade the DNA molecule and perform hydrogen ab-
straction.
The details of these steps, originally presented in Refs.
[6,38], are schematically illustrated in Figure 1 where
a red arrow shows a single track-structure of a proton
traversing a cell nucleus (circular structure). We divide
the cell nucleus into nm-size domains based on the path
length of the proton track and the dimension of simu-
lation box / voxel. Hence the size and number of do-
mains are determined by diameter of cell nucleus, the
length of track-structure and the size of simulation box
used in ReaxFF MD. An example of such configuration
is sketched in Figure 1 where a cell nucleus with diam-
eter 6µm is depicted. Furthermore, in order to score at
least one DSB, a DNA with at least 10 base pairs must
be constructed in ReaxFF MD computational box. This
requires fitting of a DNA structure with an approximate
length greater than 6 nm. Hence the track and cell nu-
cleus along the path of proton must be partitioned into
approximately 1000 segments, as depicted in Figure 1.
In each segment, we score number of DSBs using
a selective statistical sampling algorithm introduced in
Ref.[6]. Summing DSBs over the track segments yields
total number of DSBs induced by a single track in a cell
nucleus. With access to distribution of DSBs in a single
cell, we repeat the above procedures to calculate DSBs
induced by collection of independent proton tracks. By
further averaging over ensemble of cells, we obtain sta-
tistical mean of DSBs and its higher order moments in a
colony of cells. Hence, the output of ReaxFF MD simula-
tion yields the type and magnitude of the DNA damage
in nano-scale as a function of energy loss. By repeating
these steps for different locations of the scanning beam of
proton, we calculate the proton quality factor in induc-
ing DNA damage and in particular DSBs as a function
of depth and energy of proton in tissue.
The main hurdle for applying microscopic models as
such is the analysis and processing of gigabyte data ex-
tracted from ionizations and excitations in multi tracks
of charged particles that is needed for simulation of DNA
damage in a single cell. This is even more challenging if
we consider an ensemble of cells to study the effect of
radiation to an organ and a clinical object. In this case,
the computational limitations in processing of terabyte
data makes the microscopic models impractical for any
clinical application such as simulation of tumor response
and post irradiation tissue toxicity. Hence we engage
an alternative solution and adopt a higher level of spa-
tiotemporal modeling and interface Geant4DNA-ReaxFF
results to macroscopic models.
4We organize the rest of this paper to present construc-
tion of such higher-level modeling and its application in
fitting the cell survival data, however, it is important to
emphasize that it is the multi-scaling that constitutes a
framework for construction of coarse-grained modeling
employed in this study. We postpone to present more
details of this study to our forthcoming publications.
To build a coarse-grained stochastic model of DSB in-
duction by direct or indirect free radical-mediated ion-
ization effects, we consider passage of a single track of
a charged particle as shown in Figures 1 and 2. As
pointed out, we divide a DNA material in a cell nu-
cleus into nm-size virtual domains such that in each do-
main there would be a possibility in scoring at least one
DSB with probability p. By performing finite number
of Geant4DNA-ReaxFF MD simulations and scoring bi-
nary numbers for DSB counting, i.e., 0 and 1 associated
with zero and greater than zero DSB configurations, we
calculate p. Note that as we commented out earlier, p is
a function of proton depth and energy in tissue. For a
very large number of samplings over the entire domains of
DNA materials, where scoring the statistics of DSBs by a
microscopic method such as Geant4DNA-ReaxFF MD is
impractical, a Bernoulli / binomial distribution function
can be employed to determine the expected number of
DSBs and their higher order moments.
For large number of domains with typical particle flu-
ence optimized for therapeutic applications, it is reason-
able to assume p << 1 hence Poisson distribution, Pk =
(∆k/k!)e−∆ governs distribution of k = 0, 1, 2, . . . DSBs
in DNA material with mean value ∆ = k =
∑∞
k=0 kPk.
This assumption is consistent with our scoring of DSBs
calculated by Geant4DNA-ReaxFF simulation.
The probability in scoring exactly ν-events resulted
from passage of multi-track of particles is also assumed
to be Poisson distribution, Pν = (Θ
ν/ν!)e−Θ. Here
ν = 0, 1, 2, . . . counts number of events scored in DNA
material and Θ = ν =
∑∞
ν=0 νPν is the mean number of
events scored in collection of cell nuclei.
Combination of intra- and inter-track energy de-
positions, constitute a compound Poisson distribu-
tion and in particular Neyman’s distribution of type
A [53,54] that governs the probability distribution of
n DSBs in DNA material induced by collection of in-
dependent events Qn(∆; Θ) =
∑∞
ν=0 Pν(Θ)Pn(ν∆) =
e−Θ∆n/n!
∑∞
ν=0(ν
n/ν!)(Θe−∆)ν where n is the total
DSBs in DNA induced by all tracks with mean value
calculated by the average number of events, Θ, times the
average number of DSBs per event, ∆, hence n = Θ∆.
Probability of finding DNA material with zero DSBs is
given by Q0 = exp{−Θ(1 − e−∆)} ≈ e−Θ∆ = e−n, an
expression that resembles the cell SF.
B. DSB master equation: dynamics
We now turn to consider the dynamics of DSB’s. A
time-dependent Master equation, i.e., a birth-death Pois-
FIG. 1: Schematically shown the partitioning of a cell nu-
cleus (circular structure) into segments of proton-tracks (red
lines) used as unit of ionization per MD simulation of DNA
damage. The model calculation starts with scoring the ioniza-
tions and the time-evolution of chemical reactivity of species
induced by ionized water molecules, in surrounding of DNA
in sub nanometer and femto-second spatiotemporal scales. In
upper left corner, a magnified structure of DNA surrounded
by water molecules is depicted with no scored DSB induction.
Shown in upper right corner, a typical snap-shot of distorted
DNA obtained after running MD for ≈ 50 ps. Two SSBs are
highlighted by yellow circles, located within 10 base-pairs sep-
aration are indication of a DSB formation. Damaged bases,
distorted hydrogen bonds, base-stacking as well as complex
species such as hydrogen-peroxides formed from two OH. free
radicals are visible. For clarity of the visualization, we re-
moved water molecules from the image of the DNA molecule.
son process, describes the stochastic evolution of DSBs
formed on DNAs and post-irradiation intra and inter
chromosomes end-joining processes in a cell, including
repair and mis-repair mechanisms [55]. The latter ac-
counts for cellular lethal transitions and/or cell cycle
termination. The transition rates are phenomenological
parameters that describe the processes as illustrated in
Figures 2-3 throughout homologous and non-homologous
end joining. Their numerical values can be extracted by
the fitting of the present model to the RBE experimental
data [42].
The Poisson process is based on the Markov-chain
where events in time depends only on one step behind
with no long-range history from the past, as shown
schematically in Figure 2. The master equation asso-
ciated with such stochastic process is given by [56]
dQn(t)
dt
= gn−1Qn−1 − gnQn + rn+1Qn+1 − rnQn, (1)
5FIG. 2: (a) Schematic diagram of Markov process in DSB
rate equation, Eq. (1). (b) Schematic representation of DSB
induction in a cell nucleus. The bold arrow represent a
charged particle traversing cell nucleus. The wiggly lines were
adopted from Feynman’s diagrams in quantum electrodynam-
ics (QED) to describe propagation of interaction of a particle
as a field in scattering processes with an interaction-site (see
for example Ref. [66]). (c) Chromosomes undergo DSB in-
duction after track of particles traverse the cell. Colored lines
represent chromosomes and the gap between each chromo-
some represent a DSB. The black dots in the middle of each
chromosome represent centromere. Black chromosomes were
not gone through DSB formation after traversing charged par-
ticles.
FIG. 3: Diagrammatic representation of cell survival in form
of a perturbative expansion described by pair-wise, ternary,
quaternary, and N-tuple chromosome end-joining correspond-
ing to γ2, γ3, γ4 and γN in Eq. (3). Possible combinations of
lethal misrepaired lesions are sketched.
where gn, and rn are creation and annihilation rates re-
spectively corresponding to transitions n → n + 1 and
n → n − 1 in DSB inductions. Qn is the normalized
(
∑∞
n=0Qn(t) = 1) probability of occurrence of n-integer
DSBs resulted from scoring of all events in a cell.
It is straightforward to show (see Appendix A) a rate
equation that counts for overall damage, including repair
and mis-repair mechanisms, can be derived from Eq. (1)
dn(t)
dt
=
∞∑
n=0
(gn − rn)Qn, (2)
where n is average number of DSBs in DNA material.
Assuming Neyman’s distribution for DSB partition func-
tion, Qn, we find the stationary solution of Eq. (2),
n = Θ∆. Stationary solution holds only if rn = 0 (no
repair) post irradiation.
Note that the time evolution of DSBs and their inter-
action mediated by enzymatic repair mechanisms cannot
be simulated by microscopic Geant4DNA-ReaxFF MD,
at least at its current stage of development in our com-
putational capability. Hence employing a coarse-grained
model, such as the one presented in this subsection is
necessary.
C. Chromosome end joining complexities: LET
corrections
The rate of DSB induction can be approximated by
gn = µz˙ for any n. Here z and µ are the specific energy
(deposited energy per mass in unit of Gy) and the average
number of DSBs per deposition of 1 Gy of ionizing dose,
respectively, and z˙ denotes the specific-energy rate. The
repair and all mis-repair endjoining processes including,
unary, binary, ternary, quaternary, ... are incorporated
into phenomenological rate constants
rn = γ1n+ γ2n(n− 1)/2 + γ3n(n− 1)(n− 2)/3!
+...+ γNn(n− 1)(n− 2)...(n−N)/N !. (3)
The first term in Eq. (3) represents DNA repair processes
including DNA non-lethal unary end-joining. The second
term in Eq. (3) represents pair-wise DNA mis-repair pro-
cesses. It accounts for combination of two DSBs on any
pair of chromosomes out of n initially induced DSBs. The
third term in Eq. (3) represents recombination of three
DSBs out of n initially induced DSBs, i.e., ternary DNA
misrepair processes. Similarly the rest of the terms in
Eq. (3) describe quaternary, and ... recombination of
DSBs as shown in Figure 3. We note that in physical
processes, fragments of DNA are reattached during the
repair processes and not DSBs. For brevity in our ter-
minology we abbreviated combination of DNA fragments
caused by a DSB to “combination of two or more DSBs”.
Insertion of Eq. (3) in Eq. (2) and summing n over
Neyman distribution function we find
dn(t)
dt
= µz˙ − γ1n− γ2
2!
n(n− 1)− γ3
3!
n(n− 1)(n− 2)
− ...− γN
N !
n(n− 1)(n− 2)...(n−N). (4)
Expansion of moments of n in Eq. (4) can be performed
by using the identity
n(n− 1)(n− 2)...(n− r) =
r∑
s=0
csn
r+1−s∆s, (5)
where cs are expansion coefficients with c0 = 1. Hence
Eq. (4) can be reduced to a rate equation with rate con-
stants corrected for ∆
dn(t)
dt
= µz˙ − λeffn− γeffn2 − ..., (6)
Here λeff and γeff are the effective / dressed chromosome
repair and misrepair rates, renormalized by lineal-energy
6/ LET corrections and can be expressed in power series
of ∆, or equivalently LET as we demonstrate below (see
e.g., Eq. (18) and the following discussion). Hence
λeff = γ1Λ(∆) = γ1 +
γ2
2!
∆ +
γ3
3!
∆2 + ...+O(∆N−1),(7)
and
γeff =
γ2
2!
Γ(∆) =
γ2
2!
+
γ3
3!
3∆ +
γ4
4!
7∆2 + ...+O(∆N−2).(8)
Note that the series in γeff terminates at O(∆N−2)
whereas λeff terminates at O(∆N−1). Here γ1 and γ2/2
are the bare chromosome repair and misrepair rates in
the absence of corrections from higher order statistical
moments where Λ = Γ = 1. Note that Λ = Γ = 1
implies equivalence of Eq. (4) with rate equations con-
sidered in previous publications, e.g., in Ref. [32] and
the references therein where Qn is assumed to be Poisson
distribution and chromosome rejoining mechanisms, be-
yond binary were disregarded, i.e., γ3, γ4, ..., γN assumed
to be negligible. The last assumption has been retained in
a further extension of Poissonian [32] to non-Poissonian
model of DSB distributions presented in Ref. [34].
The relation between dressed and bare parameters re-
sembles renormalization of mass and charge in standard
field theories [66] and effective mass in dispersive media
in condensed matter physics [67] with close connection to
statistical corrections and zero point fluctuations to the
solutions of the Gaussian mean field theories [68–70].
We denote
SF [n(t)] = e−L[n(t)], (9)
the cell survival fraction, and L the population of bro-
ken DNAs transformed to lethally damaged chromosomes
over sufficiently long time, t → ∞. L can be calculated
from fraction of broken DNAs that undergo lethal lesions
L[n(t)] =
∫ ∞
0
dt
(
λL,effn(t) + γL,effn
2(t) + ...
)
. (10)
In Eq. (10)
λL,eff = γ1L +
γ2L
2!
∆ +
γ3L
3!
∆2 + ...+O(∆N−1), (11)
and
γL,eff =
γ2L
2!
+
γ3L
3!
3∆ +
γ4L
4!
7∆2 + ...+O(∆N−2).(12)
γ1L, γ2L, ... γNL represent transition rates of fraction
of DSBs that turn to lethal lesions through mis-repair
processes of unary, pair-wise, ternary, and higher order
DSB recombinations. Similar to λeff and γeff , we can
express λL,eff and γL,eff in power series of particle LET.
D. DSB - Lineal energy dependence
To calculate the explicit form of α and β in linear-
quadratic model as a function of lineal-energy / LET
and dose, we go one step back and expand Eq. (4) in the
following form
dn(t)
dt
= µz˙ − λn− γn2 −O(n3). (13)
Similarly
L =
∫ ∞
0
dt
(
λLn(t) + γLn2(t) +O(n3)
)
. (14)
Eqs.(13) and (14) are more general than their MKM [19,
20] and RMF models [31,32,34] counterparts. In partic-
ular, in MKM and RMF-type models, the parameters λ,
γ, λL and γL were expanded up to a linear order in LET.
In this work, however, we derive systematically expan-
sion of these parameters to higher orders in LET from
Eqs.(13) and (14).
To this end, we further split n in Eq. (13) into n0 and
n1 = n− n0. n0 is a solution of linearized rate equation,
i.e., γ = 0 in Eq. (13). A perturbative expansion of n
around n0 yields L in terms of a power series in specific
energy fluctuations (see the following section for details)
L =
λL
λ
µz +
1
2
[
λL
λ
γ
λ
+
γL
λ
]
µ2z2 +
1
3
γL
λ
γ
λ
µ3z3
+
[
−γL
6λ
γ2
λ2
+O
(
γ2
λ2
)]
µ4z4 +O
(
µ5z5
)
. (15)
To determine the functionality of α and β on LET and
LQ cell response, we further expand moments of mean
specific energy, zi for any power i, in terms of lineal-
energy by considering a typical normalized energy depo-
sition distribution function [61,63] in a 3 to 7 micrometer
size cell nucleus [13]
F (z; Θ) =
∞∑
ν=0
Pν (Θ)fν (z) , (16)
Here fν (z) is the distribution of specific energy within z
and z + dz in cell nucleus, imparted by exactly ν en-
ergy deposition events from passage of multi-track of
particles. Normalization of F implies fν to be normal-
ized, i.e., 1 =
∫∞
0
dzF (z; Θ) =
∫∞
0
dzfν (z) for any ν as∑∞
ν=0 Pν (Θ) = 1.
The occurrence of n = ν∆ DSBs resulted from energy
deposition to the entire DNA material in cell nucleus re-
quires balance in energy transfer, from radiation source
to DNA hence
fν (z) =
∞∑
n=0
Pn (µz) δ(z − ν∆/µ). (17)
Insertion of DNA final state and the DSB density of
states in form of δ-function in fν , enforces a constraint
on the energy transfer balance, in accordance with Fermi
golden rule [71]. For the consistency checks, readers can
easily calculate the norm of fν from the last equation
and show 1 =
∫∞
0
dzfν (z) =
∑∞
n=0 Pn (ν∆) for any ν.
7Moreover one can show fν(z) =
∫
dz′f1(z′)fν−1(z − z′)
where f1(z) is the single event specific energy distribution
function. Substituting fν (z) in Eq. (17) to Eq. (16) and
integrating over z yields both the DSB partition func-
tion, Qn (∆; Θ) =
∑∞
ν=0 Pν (Θ)Pn (ν∆), and correlates
∆ with zD, the standard deviation of z over whole cell
domain population
zD =
z2 − z2
z
=
∆
µ
, (18)
where z2 =
∫∞
0
dzz2F (z; Θ) = D(D+∆/µ) = D(D+zD)
and z =
∫∞
0
dzzF (z; Θ) = Θ∆/µ = n/µ = D is the
macroscopic / mean dose.
Hence, insertion of fν given in Eq. (17) to Eq. (16)
weighted to powers of z following by integration over
z and summing over ν, lead to analytical equations
for α and β where z = D, z2 = D(D + zD), z3 =
D3+3zDD
2+z2DD, z
4 = D4+6zDD
3+18z2DD+z
3
DD, · · ·.
Insertion of these identities in Eq. (15) account for the
spatial averaging of the energy deposition fluctuations in
cell radiation lethality or toxicity. In general, calculation
of higher order fluctuations in specific energy over the cell
nuclei, zi, can be recursively expanded to lower power
moments, zi =
∑i
j=1 z
i−j
ij z
j =
∑i
j=1 z
i−j
ij D
j . Here zi−jij
are expansion coefficients derived exactly from Neyman’s
distribution functions. zi can be converted to power se-
ries in terms of a single variable, zD
zi = Di + (b01 + b11zD)D
i−1
+
(
b02 + b12zD+b22z
2
D
)
Di−2 + . . .
+
(
b0i + b1izD+b2iz
2
D + . . .+ biiz
i
D
)
D. (19)
bij are numerical coefficients, independent of zD and dose
with numerical values calculated formally throughout an
inverse transformation zi−jij =
∑i−j
k=0 bk,i−jz
k
D. In de-
riving the above equation one can start from (µz)i =∫∞
0
dz(µz)iF (z; Θ) =
∑∞
n=0 n
iQn(∆; Θ), which allows
use of transformation ni → (µz)i in Eq. (5) and turn it to
a form given by Eq. (19). As pointed out above, and can
be seen in Eq. (19), zi can be expressed in a power series
of a single microdosimetry variable, zD. This is seemingly
character of Neyman, Poisson and Gaussian distribution
functions as expansion of zi cannot be represented only in
terms of powers of zD for a general distribution function,
i.e., the one calculated by MC.
With these identities, one can convert the DSB distri-
bution function, Qn, and express it in terms of deposited
dose, D, and calculate the cell survival in multi-target
theories [72,73]. However, because of lack of postirradi-
ation microscopic biological responses in these theories
and adhoc mechanistic assumptions on cell deactivation
after specific number of hits as well as lack of clarity
in dependence of biological parameters on lineal-energy,
we carry on with calculation of the cell-survival through-
out the dynamical chromosome repair and mis-repair pro-
cesses and temporal fluctuations in Markov chain, that
yields
−ln(SF) = αD + βD2 +O(D3), (20)
where
α =
λL
λ
µ+
1
2
[
λL
λ
γ
λ
+
γL
λ
]
µ2zD +
1
3
γL
λ
γ
λ
µ3z2D
+
[
−γL
6λ
γ2
λ2
+O
(
γ2
λ2
)]
µ4z3D +O
(
µ5z4D
)
, (21)
and
β =
1
2
[
λL
λ
γ
λ
+
γL
λ
]
µ2 + 3
1
3
γL
λ
γ
λ
µ3zD
+ 18
[
−γL
6λ
γ2
λ2
+O
(
γ2
λ2
)]
µ4z2D +O
(
µ5z3D
)
.(22)
Specific relations and conditions among expansion co-
efficients in α and β, as shown in Eqs. (21-22), are char-
acteristics of Neyman’s distribution function. To employ
a similar model for fitting the SF data, it would be rea-
sonable to score the distribution functions directly by
performing MC and subsequently fitting the numerically
calculated energy loss spectrum to Landau / Vavilov dis-
tribution functions [74,75] as discussed in Ref. [42]. Be-
cause these distribution functions are slightly different
and show deviation from Neyman’s distribution function,
they result in α and β in series expansion of moments of
z, but in more complex form compare to Eqs. (21-22). In
general
α =
λL
λ
µ+
1
2
(
λL
λ
γ
λ
+
γL
λ
)
µ2z21
+
1
3
γL
λ
γ
λ
µ3z231 + . . . , (23)
and
β =
1
2
(
λL
λ
γ
λ
+
γL
λ
)
µ2 +
1
3
γL
λ
γ
λ
µ3z32 + . . . . (24)
Except z21 that is identical to zD, the other coefficients,
zij , are not necessarily proportional to zD, however they
can be expressed as a non-linear function of zD. We
postpone the details in derivation of these equations to
Sec. II G.
E. Lineal energy - LET dependence
To apply above formulations to numerical fitting pro-
cedure and the experimental data, change of variables
and more specifically transformation from zD to yD and
subsequently to LETd is required. To proceed, we de-
fine zD = l(y1D/m) where l is the mean stepping length
and m is mass of DNA material under exposure. In con-
trast to standard microdosimetry where l is defined as
the mean chord length, a constant specific to geometri-
cal structure of a microdosimetry volume, we consider l
8a variable that can be calculated by event by event MC
simulation of track structures in a voxel in the target vol-
ume, hence l is a function of depth as shown in Figure 4,
i.e., independent of proton energies. In Figure 4(a) l and
energy deposition, normalized to its value at the Bragg
peak, e.g., the beam percentage depth dose (PDD), is
shown as a function of depth. In high energies, in the
beam entrance, l varies as a function of beam energy. In
low energies, in the vicinity of the Bragg peak, l shows
no variation in beam energy, a universal character. In
Figure 4(b) the energy deposition in SF, εD = ε2/ε is
shown and in Figure 4(c) four types of LET averaging,
y-averaged LET, yD = y2/y, dose-averaged LET, LETd
and two types of track-averaged LETs, LETt = ε/l and
y1D = εD/l vs. depth are depicted.
Out of these four LET’s, y1D, as defined in this study,
has been used in formulation of SF where by replacing
zD = ∆/µ we may introduce a quantity that can be
interpreted as a measure of number of induced DSBs per
track length, ∆l = ∆/l
∆
l
=
µ
m
y1D. (25)
Similar to y1D, ∆l is a function of depth and can be
calculated by event by event MC simulation as described
above.
Calculation of y1D is based on single event specific dis-
tribution function where zD = εD/m = z21/z1. Here
z1 =
∫
dzzf1(z) = zF and z21 =
∫
dzz2f1(z), hence y1D =
m(z21/z1)/l. The equivalence between zD in single event
and multi-events given by Eq. (18) can be found through
the Fourier transforms of F (z; Θ) and fν(z) subjected
to convolution of fν ’s, fν(z) =
∫
dz′f1(z′)fν−1(z − z′),
as described in Ref. [61]. More explicitly, zD = z21/z1 =
(z2−z2)/z. We apply these equations in average number
of DSB per track, ∆ = µzD, and subsequently to Eqs.(7-
8) and Eqs.(11-12) to express repair-misrepair effective
rates
λeff = γ1 +
γ2
2!
µzD +
γ3
3!
µ2z2D + ...
+ O ((µzD)N−1) , (26)
and
γeff =
γ2
2!
+
γ3
3!
3µzD +
γ4
4!
7µ2z2D + ...
+ O ((µzD)N−2) , (27)
and their lethal lesion counterparts
λL,eff = γ1L +
γ2L
2!
µzD +
γ3L
3!
µ2z2D + ...
+ O ((µzD)N−1) , (28)
and
γL,eff =
γ2L
2!
+
γ3L
3!
3µzD +
γ4L
4!
7µ2z2D + ...
+ O ((µzD)N−2) . (29)
It is also straightforward to calculate mean frequency
(single event) specific energy, zF =
∫∞
0
zf1(z) = ∆/µ,
hence we obtain zF = zD. Note that this equation
does not hold in general. It is seemingly a result of
particular symmetries and choice of Neyman’s distri-
bution function, we considered for our analytical stud-
ies. Similar to multi-event processes, α and β can
be calculated by Eqs. (23-24). By expanding zij in
Eqs. (23-24) around zD, e.g., zn =
∫∞
0
dzznf1(z) =∫∞
0
dz(zD + δz)
nf1(z) =
∑n
k=0
n!
k!(n−k)!z
k
D
∫∞
0
dz(z −
zD)
n−kf1(z) =
∑n
k=0
n!
k!(n−k)!z
k
Df˜n−k(zD) where δz =
z − zD and f˜k (zD) =
∫∞
0
(z − zD)kf1(z)dz, and using
zij = lyij/m, one may find α and β to be a power se-
ries in y1D, α =
∑N
i=0 a
′
iy
i
1D and β =
∑N−1
i=0 b
′
iy
i
1D. Here
a′i and b
′
i are considered as adjustable phenomenological
expansion coefficients.
Note that subscript 1 introduced in y1D intended to
distinguish y1D = m(z21/z1)/l from yD = y
2/y. The lat-
ter is analogous to y-averaged LET, LETy and applied
formally in MKM to describe the linear dependence of
α on LET, see, e.g., Eq. (26) in Ref. [19]. Figure 5(a)
illustrates the difference between y1D and yD for series of
pencil beams of protons calculated by Geant4 MC tool-
box [59].
In MC we scored y1D and yD from event
by event energy deposition dεj and step-
ping length dlj , using the following identities
y1D = (
∑
j(dεj)
2/
∑
j dεj)/(
∑
j dlj/
∑
j 1j) and
yD =
∑
j(dεj/dlj)
2/
∑
j(dεj/dlj) where sum over j
includes all energy deposition events from primary and
secondary processes in all steps in a specific voxel, hence∑
j 1j represents total number of scored energy deposi-
tion events. Our approach in scoring y1D and yD (as well
as other LETs), is based on drawing random variables,
z and y, from single event distribution functions f1(z)
and S(y), generated on-the-fly by Geant4 MC toolkit.
Interested readers may find more details in Appendix
B, however, our approach is equivalent to the scoring
method in microdosimetry and the inchoate distribution
of energy transfers, introduced by Kellerer in series of
publications, see for example Refs. [52,63–65].
To investigate variation of y1D and yD, and their de-
pendence on the experimentally reported dose averaged
LET, we employ the above methodology and convert
y1D and yD to LETd. The results of these calculation
for pencil beams of 106 protons with nominal energies,
80, 90, 100, 110 and 120 MeV are shown in Figure 5
where a universal relation, i.e., independent of proton
energies, between different forms of LET’s is evident.
The one-to-one correspondence between y1D and LET,
as seen in Figure 5, rationalize the deduction of the fol-
lowing polynomial expansions α =
∑N
i=0 aiLET
i
d and
β =
∑N−1
i=0 biLET
i
d. It is worth mentioning three do-
mains in LETd, roughly below, within and above 5 and
15 keV/µm where the linear relationships between y1D
and LETd (as well as other LET’s) change slope. In
9particular, in fitting LETd and dose, D, as two inde-
pendent variables to the experimental SF data, we infer
three types of dependencies on LETd, within these three
domains. We return to this point in Sec. IV A where we
partition SF data points into classes with low, interme-
diate and high LETd values respectively.
Note that in the present study, we refer to high and low
LETs within the experimental range, relevant to the cell-
survival data points as reported in Ref. [13] where LET
= 20 keV/µm is the maximum experimentally reported
value. Within this range of LETs, we consider LET =
5 and 15 keV/µm, two limiting values that separate low
and high LET domains, in spite of possibilities in scoring
even much higher LETs, i.e., above 40 keV/µm, close
to the last µm’s in tail of proton range, where the last
cells experience passage of low energy (less than 500 keV)
protons.
F. Linear DSB solutions and linear-quadratic (LQ)
cell survival
We now turn to calculate solutions of DSB and lethal
lesion rate equations. First we consider a limiting case
for n where a linear approximation in Eq. (14) can be
obtained by neglecting γ in the rate equations. This so-
lution has been used frequently in modeling RBE in lit-
erature. In particular in MKM, e.g., see Eq. (7) in Ref.
[19].
Insertion of γ = 0 in the rate equation permits access
to analytical solution of Eqs. (13) and (14). Recalling
the Green’s function method, we can easily convert the
differential equation into an integral equation
n0 (t) =
∫ +∞
−∞
dt′Gr (t− t′) z˙ (t′) . (30)
Here n0 is the solution of Eq. (13) in the linear approxi-
mation. It is straightforward to justify that the homoge-
neous solution to Eq. (13) is identical to zero, thus we do
not consider it in Eq. (30). It is also a straightforward
calculation to show the retarded Green’s function follows
Gr (t− t′) = µe−λ(t−t
′)θ (t− t′), where θ (t− t′) is the
Heavyside function, i.e., θ = 1 if t ≥ t′ and 0 otherwise.
The steps in calculating Gr include converting the inte-
gral equation, Eq. (30), to a differential equation for Gr
by substituting (30) in (13) and imposing the initial
condition n0 = 0 for t < 0 where z˙ = 0. Similarly we
define SF 0 = e
−L0 where L0 =
∫ +∞
−∞ dt
′
[
λLn0 + γLn20
]
.
Here the bar over L0 denotes energy deposition averag-
ing on the ensemble of cell nuclei domains, specific to a
lineal-energy distribution.
For an acute radiation dose, z˙(t) = zδ(t), the solu-
tion of Eq. (30), n0(t) = µze
−λtθ (t), leads to L0 =
λL
λ µz+
γL
2λµ
2z2 where by averaging over the lineal-energy
distribution and all cell nuclei and their domains we ob-
tain a linear-quadratic model in cell-survival
−ln (SF ) = αz + βz2, (31)
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FIG. 4: Shown (a) l and energy deposition percentage depth
dose normalized to its value at the Bragg peak (PDD) (b)
energy deposition modeled in SF, εD = ε2/ε and (c) four
types of LET averaging used in this work vs. depth for pencil
beams of protons with nominal energies, 80, 90, 100, 110,
and 120 MeV. The letters D, d, t and 1D, denote lineal-energy
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y1D and (c) yD vs. LETd calculated by Geant MC toolkit.
The simulation consists of 106 particles in water phantom. A
universal linear relation in low LET less than 5 keV/µm is
visible. As LET increases a non-linear dependence emerges
and the lines show slightly divergence because of energy loss
straggling in the end of proton range.
where α = λLλ µ +
γL
2λµ
2zD and β =
γL
2λµ
2. Here we use
the identity z2 = z (z + zD).
We further recall relation zD = ly1D/m where m = ρV
is the average mass in a spherical volume V surrounding
the point of energy deposition, as introduced in the in-
choate distribution of energy transfers in microdosimetry
by Kellerer, Rossi and their colleagues [52,63,64] and ρ
is the water equivalent mass density. Therefore, we ob-
tain α = λLλ µ+
γL
2λµ
2 1
ρ(V/l)
y1D. Considering α and β as
phenomenological parameters and V/l = pir2d we end up
with two relations
α = α0 + β
1
ρpir2d
y1D, β = βx. (32)
Note that Eq. (32) resembles the frequently used relation
in literature (see e.g., Eq.(II.28) in Ref. [19] or Eq. (8)
in Ref. [21]) if we assume zD = `yD/m and ` denotes the
average chord length of a MKM domain.
Considering a piece-wise linear relation between y1D
and LETd, for a domain of LETd, less than 5keV/µm
and greater than 15keV/µm, as shown in Figure 5(b),
one may suggest an approximate linear relation between
α and LETd, i.e., α = α0 +α1LETd. Here α0, α1, β0 and
rd are four fitting parameters with only three indepen-
dent parameters. Note that α1 is linearly proportional
to β/(ρpir2d). Because of piece-wise linear dependence be-
tween y1D and LETd, as illustrated in Figure 5, the corre-
sponding coefficient changes value at LETd = 5keV/µm
and LETd = 15keV/µm.
Alternatively one can fit a polynomial to y1D-LETd
curve and obtain α a non-linear function of LETd. Note
that, because in Eq. (32), β does not change by variations
in LETd as it is constant and independent of y1D, α/β
increases monotonically as a function of LETd. In the
following section, we discuss the presence of other sources
that contribute to the non-linearities of α as a function
of y1D. Same mechanisms contribute to dependence of
β on y1D. Therefore we argue that both α and β are
non-linear functions of LETd.
G. Non-linear expansion of DSB solutions, going
beyond LQ cell survival
In this section, we continue with performing a pertur-
bative expansion to calculate the non-linear solution of
Eqs. (13) and (14). To go beyond the linear solutions
presented in the preceding section, we assume γ to be a
small parameter, hence we expand n about n0 perturba-
tively and linearize the resulting rate equation to obtain
the dynamics of the small fluctuations describing devia-
tions from linear DSB solutions. We define n1 = n− n0
and recall Eq. (13) to obtain a linear equation for n1
dn1
dt
= −λn1 − γ
(
2n0n1 + n
2
0
)
+O (n21) . (33)
Here n is the exact solution of Eqs. (13) and (14). By
definition, n0 is the exact linear solution of these equa-
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tions, hence n1 describes the difference between exact
and linear solutions. It is more convenient to transform
Eq. (33) into a more compact form
dn1
dt
+ η (t)n1 (t) = ξ (t) , (34)
where η = λ+2γn0 and ξ = γn
2
0. The solution of Eq. (34)
can be calculated exactly
n1 (t) = e
−ϕ(t)
∫ t
−∞
dt′ξ (t′) eϕ(t
′), (35)
where ϕ (t) = λt+ 2γ
∫ t
−∞ dt
′n0(t′). Linearizing Eq. (35)
in terms of γ, assuming γ is a small parameter, leads to
n1 (t) = γe
−λt
∫ t
−∞
dt′n20(t
′)eλt
′
+O
(
γ2
λ2
)
. (36)
Substituting the linear solution calculated above,
n0(t) = µze
−λtθ (t), in Eq. (36) yields
n1 (t) =
γ
λ
µ2z2
(
1− e−λt) e−λt, (37)
hence
n = n0 + n1 = n0 −
γ
λ
[n0 − µz]n0 +O
(
n30
)
. (38)
From Eq. (38) and n0, the cell-survival can be calcu-
lated, −ln (SF) = ∫ +∞−∞ dt′ [λLn+ γLn2], hence we ob-
tain Eq. (15) as given below
−ln(SF) = λL
λ
µz +
1
2
[
λL
λ
γ
λ
+
γL
λ
]
µ2z2 +
1
3
γL
λ
γ
λ
µ3z3
+
[
−γL
6λ
γ2
λ2
+O
(
γ2
λ2
)]
µ4z4 +O
(
µ5z5
)
.(39)
The last two terms in Eq. (39) are the contribution of
the terms omitted in Eq. (36) due to linearizing n in the
limit where γ is negligible. To transform (39) to a form
similar to the linear-quadratic model, we must calculate
the statistical fluctuations in microscopic dose deposition
throughout the averaging over cell nucleus domains, as-
suming equivalence between the ensemble averaging over
the domains and the spatial averaging of the energy de-
position fluctuations over the cell nuclei.
Similar to linear model discussed in preceding section,
for numerical fitting of the experimental data we trans-
form y1D to LETd using the relations obtained from MC
simulation, as depicted in Figures (5). However, because
in non-linear SF model, both α and β vary as a func-
tion of y1D, with increase of LET beyond 5 keV/µm, a
more rapid non-linearity in α, β and RBE as a function
of LETd is expected.
Note that the general formalism presented in this study
allows insertion of an arbitrary dose rate, z˙(t), in the rate
equations where the linear solutions to the cell lethality
can be obtained through numerical integration over the
dose rate, z˙(t), convolved with the retarded Green’s func-
tion, Gr (t− t′) in Eq. (30). Subsequently, the numerical
integration over the linear solution permits calculation of
the non-linear corrections.
III. CELLS BIRTH-DEATH MASTER
EQUATION: TUMOR GROWTH DYNAMICS
We now turn to incorporate the time evolution of DSBs
to the growth rate of the cells, in particular in tumors
where the cells and their offsprings tend to double their
population exponentially through mitotic / meiotic cy-
cles. The growth in cell population is, however, in bal-
ance with apoptotic / necrotic cell death pathways.
Although, it is known for decades that the major ther-
apeutic gains in applying ionizing radiation, and in par-
ticular, induction of DSBs, is to alter the growth rate bal-
ance toward the cell death and disruption of the growth
factors and enforcing the tumor shrinkage, but because
of deficiencies in quantitative biological optimizations in
TPSs, there is still a need for improving model calcula-
tions. There are, however, fundamental computational
challenges that does not permit incorporation of the ini-
tial events, e.g., the DSB inductions and their interfer-
ence with the cell growth pathways in the current TPSs.
This is mainly because of the entanglements of the dispar-
ities in two vastly separated spatial and temporal land-
scapes in any computational model as pointed out in the
beginning of Sec. II A. More specifically, while the oc-
currence of the initial ionizing radiation events and DSB
formations have been realized in nano-meter and femto
to picosecond scales, the therapeutic / clinical endpoints
of the tumor growth can be captured in centimeter and
days or even weeks and months. Thus there are several
orders of magnitude difference between initial and final
events of interest. To be able to model the hierarchy of
the events and their pathways in a logical and algorithmic
methodology, e.g., under a unified simulation toolbox, a
coarse-grained multi-scale approach must be engaged to
close the gap between microscopic events at the molecular
levels and their macroscopic resemblance at the biolog-
ical / clinical endpoints. We note that our multi-scale
methodology is consistent with a multiscale framework
that have been developed and applied successfully to de-
scribe cellular response and RBE for ion irradiation by
proton and ion beam therapy, [8,9].
To achieve this goal, we consider a minimal mathemat-
ical approach relevant for cell growth by applying a com-
putational model similar to the time-dependent master
equation, proposed in preceding sections to simulate the
dynamical processes of DSBs in nano-meter scale. This
model is, however, in macroscopic scale. To this end, we
consider a birth-death Poissonian / Markovian process
to describe the stochastic growth of a colony comprise of
collection of weakly-interacting cells. The master equa-
tion associated with such processes provides normalized
probabilities, TN (t), with
∑∞
N=0 TN (t) = 1, and N de-
noted as the number of cells at moment t, in a colony
that resembles population of N weakly correlated cells
dTN (t)
dt
= bN−1TN−1−bNTN+dN+1TN+1−dNTN . (40)
bN and dN represent the rates of birth and death in mi-
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totic / meiotic cell division processes and apoptotic /
necrotic mechanisms respectively. In this model, transi-
tions in cell population only by a single step, N → N+1,
or, N → N − 1, have been taken into account.
It is straightforward to show the rate equation asso-
ciated with Eq. (40) is given by (the derivation of this
equation is similar to rate equation derived for DSBs and
presented in Appendix A)
dN(t)
dt
=
∞∑
N=0
(bN − dN )TN (t). (41)
For simplicity in modeling, it is customary to consider
constant rates, linearly proportional to the cell popu-
lation, bN = bN and dN = dN in the absence of any
therapeutic modality such as radiation (see for example,
Ref. [77]), hence dN/dt = (b− d)N .
In the next step, we incorporate the effect of ionizing
radiation to Eq. (41) by recalling in-vitro cell survivals,
SF = e−L, calculated in the preceding sections and its
basic definition, SF = N∞/N0, the ratio of the cells at
the biological endpoint, N∞, survived out of initial num-
ber of the seeded cells, denoted by N0. Therefore a simi-
lar rate equation to Eq. (41), can be proposed to correlate
N∞/N0 with L using SF formulation
dN(t)
dt
= −L(t)N(t), (42)
where L(t) is the integrand of L, i.e., L =
∫∞
0
dtL(t).
The time dependence of L(t) stems from the dynamics of
DSBs in cell nuclei in microscopic scale where by referring
to Eq. (10), we consider L(t) = λL,effn(t)+γL,effn
2(t)+...,
and from Eq. (38), we have n(t) = n0(t)− (γ/λ)(n0(t)−
µz)n0(t) +O
(
n30
)
, and n0(t) = µze
−λtθ(t).
We further carry on with combining the rate equa-
tions, Eqs. (41) and (42), that assert bN = bN and
dN = dN + L(t). Hence the tumor rate equation, in-
cluding the ionizing radiation effect, is given by
dN(t)
dt
= (b− d− L(t))N(t). (43)
Similarly the time evolution of TN is given by
dTN (t)
dt
= b(N − 1)TN−1 + (d+ L(t)) (N + 1)TN+1
− (b+ d+ L(t))NTN . (44)
From Eq. (44), we calculate TCP, under the condition
that all irradiated cells were gone through the lethal le-
sions, and subsequently no tumor cell survived the expo-
sure of ionizing radiation, hence TCP = TN=0(t = ∞).
Calculation of TN using the generating function tech-
nique and method of characteristics can be found in
Refs. [56,57] thus we skip to present the details of this
calculation. Accordingly,
TCP [n(t)] = (1− SFeff [n(t)])N0 , (45)
where
SFeff [n(t)] =
e(b−d)t−L[n(t)]
1 + be(b−d)t−L[n(t)]
∫ t
0
dt′e−(b−d)t′+L[n(t′)]
,(46)
is effective SF of each individual cell. From Eq. (46), it
should be clear that n(t) is a source that resembles driv-
ing force in TCP. Like the action in Lagrangian dynamics
of classical particles that is a functional of the particle
trajectory [60], SFeff is a functional of DSB dynamical
trajectories n(t) where
L [n(t)] =
∫ t
0
dt′
(
λL,effn(t
′) + γL,effn2(t′) + ...
)
, (47)
is a functional integral of n(t). An optimal solution to
TCP and SF can be sought by performing a functional
variation of SFeff with respect to n(t). A solution to
TCP is required to minimize SFeff in the phase space of
DSB trajectories
δ
δn(t)
SFeff [n(t)] = 0, (48)
where δn(t) stands for functional derivatives [67–69]. A
solution to Eq. (48) that maximizes SFeff can be consid-
ered for normal tissues.
A simple solution to this equation can be derived by
neglecting non-locality in time evolution of lethal lesions
in Eq. (46)∫ t
0
dt′e−(b−d)t
′
eL[n(t
′)] → 1− e
−(b−d)t
b− d e
L[n(t)]. (49)
For an acute dose of radiation in a single fraction at the
cell biological endpoint, where t → ∞, we consider a
stationary solution for L, a variable that is a constant
of time. In Secs. II F and II G, we showed that L fol-
lows a linear-quadratic type-relation in dose with α and
β that are polynomials of lineal-energy, y, and / or LET,
i.e., L = αD + βD2 + γD3 + O(D4). Considering this
stationary solution for L, we subsequently find SFeff =
e(b−d)t−L/
[
1 + b/(b− d)(e(b−d)t − 1)] ≈ e−L(b−d)/b, as
t → ∞. For typical cancerous cells, the rate in the cell
natural death process is negligible relative to their growth
rate, hence d << b. In this limit, Eq. (45) can be simpli-
fied to
TCP (∞) =
(
1− e−L[n(∞)]
)N0
= (1− SF )N0 . (50)
These equations exhibit interplay of sequence of events
starting from DSB induction by ionizing radiation in mi-
croscopic scale that propagate to formation of DNA dam-
age and chromosome misrepairs to a coarse-grained tu-
mor dynamical responses in macroscopic scale. They gov-
ern underlying mechanisms that constitute multi-scale
formulation of the cell deactivation theory in hadron ther-
apy.
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IV. RESULTS
A. Numerical fitting procedure
The numerical comparison of the proposed analytical
model presented in this work and the result of fitting
to the clonogenic cell-survival data [13] in low and high
LETs are shown in Figure 6, and series of Figures in
Ref.[42].
The fitting method is based on a three-parameter
global fitting, e.g., a multi-variate modelling of cell sur-
vival [81]. The numerical steps involve an optimization
procedure that allows fitting of a 2D surface in a 3D pa-
rameter space spanned by dose, LETd and SF. In this
approach, the intrinsic correlations in cell survival data
are incorporated into the optimization algorithm. As a
result, background fluctuations of the extracted parame-
ters α and β of the linear quadratic model due to uncer-
tainties in the biological data are considerably reduced.
The technical difference between the present fitting ap-
proach, shown in Figure 6, and similar figures shown in
Ref. [42] is the way that we manipulated the extrapola-
tion between low and high LET data points, in an inter-
mediate domain of LET as described in the following. In
the present approach, based on the experimental points
where LET = 20 keV/µm is the maximum experimen-
tally reported value, we divide the entire domain of LET
into three regions of low, LETd ≤ 5.08keV/µm, high
LETd ≥ 10.8keV/µm, and intermediate LET. The data
points in low and high LET’s are interpolated by a linear
and nonlinear LET models as described in Ref. [42].
In a similar step, as described in Ref. [42], a numerical
relation between cell survival, dose and LET has been
extracted after calculation of α, β and RBE where the
fitting has been performed for each individual survival
curve with a specific average LET. However, because of
lacking of the experimental data in the intermediate LET
domain, i.e., 5.08 < LETd < 10.8, and because the fit-
ted surfaces in low and high LETs converge to different
power law dependencies in LETd, any simplistic extrap-
olation of the data points from low and high to inter-
mediate LET, causes a discontinuity in RBE and/or its
derivatives.
To achieve a continuous and smooth RBE on the en-
tire range of LETd, including in intermediate domain, in
the present study we performed a post processing multi-
variate regression fitting model to connect the low- and
high-LET RBE points. The result of this fitting in 3D-
space of SF, dose and LET is shown in Figure 6. The
calculated RBE shows a smooth and continuous transi-
tion from low to high LETs spite that there is a large
gap in the experimental data within intermediate LET
domain.
Notice that to obtain a smooth surface in extremely
low doses we added SF = 1 at D = 0 for any LET to
the experimental data-set and fitted the points. How-
ever, because of lack of experimental data in low doses,
we cannot assess the accuracy of the fitted surface in ex-
tremely low dose limits.
The fitted RBE has been compared with several models
in the literature including MKM [19–21], LEM [22–26],
linear models of Wilkens and Oelfke [27], Steinstra¨ter et
al. [33], and MCDS-RMF [34–36]. Figure 4 in Ref.[37]
shows a sample of such comparison between prediction of
these methods and the experimental data. Accordingly,
these models are not able to explain the non-linearity of
RBE at high LETs as reported by Guan et al. [13]. As
shown in series of figures in Ref. [42], for low LET values,
a linear dependence of α and constant β on LET consis-
tent with the fitting procedures introduced in other publi-
cations including in the above references have been found.
Contrary to these models, the present method is capable
of capturing the non-linear increase of RBE as a func-
tion of LET, in particular in high LETs. In particular,
in domains beyond the Bragg peak where the stopping
power reaches to its divergence point and the difference
between the linearly fitted surface and the experimen-
tal data grows, the present model successfully captures
smooth transition from low to high LET domains. The
details in computational steps and error analysis in fitting
procedure of the present model including the goodness of
the 3D global fit can be found in Refs. [39,42].
Further inspection of the lineal-energy histograms as a
function of track position in water reveals an abrupt tran-
sition in the energy loss spectrum in Bragg peak that re-
sembles the aforementioned non-perturbative divergences
in the series expansion representation of the biological re-
sponse functions in high LET limits. As demonstrated
analytically in the preceding sections, the present study
suggests that the difference between the data and the fit-
ting models can be reduced by incorporating non-linear
polynomials in α, and β, calculated by taking into ac-
count three mechanisms due to (a) transition in the en-
ergy loss spectral density and considering a boundary
that separates the spectrum of high energy particles from
low energy particles, i.e., at Bragg peak, as well as the
deviations of (b) energy loss from Poisson distribution
in track structures and (c) chromosome aberrations from
binary end-joining.
B. Lethal lesions
We now turn to investigate the prediction of the
present model, i.e., Eq. (15), on the lethal lesions as a
function of absorbed dose and LET. Figures 7 and 8
show the lethal and relative lethal lesions, respectively,
as a function of absorbed dose for different LETs, calcu-
lated by LQ model L = αD + βD2. As introduced in
Refs. [39,42] and described in this work, the experimen-
tal values for α and β were calculated from a polyno-
mial expansion and 3D global fitting approach to obtain
the best-fitted surface to the experimental data [13]. As
seen in Figure 7, the present model predicts a substan-
tial increase in lethal lesions in LET’s corresponding to
the domains close to and beyond the Bragg peak where
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FIG. 6: Shown H460 and H1437 cell survival as a function
of dose (Gy) and dose averaged LETd (keV/µm). The blue
dots are the result of 3D surface fitting to the experimental
data presented in Ref. [42] with a gap between low and high
LETs, 5.08 ≤ LETd ≤ 10.8. This gap appears because of
lack of experimental data in intermediate domain of LET’s.
In low and high LETs two sets of linear and non-linear poly-
nomials used. The fitted surfaces to the blue dots are the
result of second / post-processing fitting procedure presented
in this work that provides a continuous and smooth connec-
tion between low and high LET data sets within intermediate
domain of LETs.
LETd ≥ 10.8keV/µm.
Similarly, the results of our calculation on the relative
lethal lesions presented in Figure 8 where a normalization
to the lethal lesions corresponding to the lowest experi-
mentally accessible LET, e.g., LETd = 0.9keV/µm has
been performed. Interestingly, as seen in Figure 8(a), in
this scale, the relative lethal lesions as a function of dose
in low LET’s resemble straight lines coincide on the top
each other. To distinguish the differences between curves
corresponding to low LET’s, we magnified and depicted
low LET curves in Figure 8(b).
Hence our model predicts small variation in relative
lethal lesions in a wide interval of beam range, e.g.,
from the beam entrance to the Bragg peak. This is
in contrast to the narrow range of distal points to the
Bragg peak, e.g., high LET’s, that the lethal lesions in-
crease abruptly, a manifestation of the non-linearity in
RBE. As expected, in low doses, where L scales lin-
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FIG. 7: Shown H460 lethal lesions per cell as a function of
dose and LETs. The lethal lesions calculated using linear-
quadratic model L = αD + βD2. The labels over each line
represent experimental values of LET for specific lethal lesion
curve.
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FIG. 8: Shown H460 (a and b) relative lethal lesions per cell
as a function of dose for different LETs. The relative lethal
lesions, L(LETd)/L(LETd = 0.9), were calculated using 3D
global fitting of the experimental cell survival data within
LQ model. It represents L(LETd), normalized by the lethal
lesions at the lowest LET, L(LETd = 0.9). For a better vi-
sualization of relative lethal lesions in low LETs, a magnified
version of (a) is shown in (b).
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early with deposited dose, the relative lethal lesions starts
from L(LETd)/L(LETd = 0.9) = α(LETd)/α(LETd =
0.9) where L(LETd)/L(LETd = 0.9) is the maxi-
mum, as L monotonically increases with the increase
of LETd [39,42]. With increase in the deposition dose,
L(LETd)/L(LETd = 0.9) drops and approaches to a
saturation value, given by L(LETd)/L(LETd = 0.9) =
β(LETd)/β(LETd = 0.9). Similar to α, the 3D global fit-
ting of the experimental data has shown that β increases
with the increase of LETd, but with slower rate such
that α/β > 1 hence L(LETd)/L(LETd = 0.9) |D→0>
L(LETd)/L(LETd = 0.9) |D→∞.
A simplistic interpretation of the lethality as a func-
tion of dose and LET, as shown in Figure 8, indicates
that as dose increases, the dependence of biological ef-
fect (relative number of lesions, complexity of damage,
etc.) on LET decreases. More specifically, because of
dominance of β in cell-survival in high doses and the fact
that α/β is an increasing function of LET (see Ref. [42]
for details on dependence of α/β on LET), the stronger
LET dependence, originated from α diminishes in favor
of weaker LET dependence in β. Therefore a decline in
lethality as an increasing function of dose for a given LET
is expected.
Note that in models such as MKM, and MCDS-RMF
where β is assumed to be independent of LETd, the rela-
tive lethal lesions in high doses is predicted to approach
to unity independent of LETd, e.g., L(LETd)/L(LETd =
0.9) |D→∞= 1. According to the predictions of the
present model, by counting the number of lethal lesions,
γ-H2AX or Foci, and their asymptotic behavior in high
doses, one can determine the dependence of β on LETd
from an independent measurement [76].
Recently, in an unpublished dataset, Bronk et al. re-
ported a dose and LET-dependent measurement of DNA
DSB repair Foci above endogenous background which
persist for 24 hours following irradiation [76]. Similar
to the predicted lethal lesions, as shown in Figures 7 and
8, the “persistent” Foci show a rapid increase near the
Bragg peak and beyond. The experimentally selected
persistent Foci are a subclass of Foci which presumably
correspond to single hit hence their counts increases lin-
early in dose with a slope proportional to α. The predic-
tion of the current model on such lethal lesions, modeled
by L ∝ αD is qualitatively in agreement with the exper-
iment. One of the important outcomes of this measure-
ment is the divergence of lethal lesion lines corresponding
to different LETd’s in high doses that indicates the de-
pendence of β on LETd. Further studies are on the way
to converge the theoretical predictions with experiments.
C. Tumor control probability
To incorporate the LET dependence of TCP, we first
start with a single voxel. In general such TCP depends
on cell-line, number of embedded tumor cells in voxel,
dose, and LET and number of treatment fractions. Con-
sidering a voxel with label k in a tumor with an average
number of tumor cells, Nk, we formally calculate a single
fraction TCP by
TCPk = (1− SFk)Nk , (51)
where SFk = exp(−α(LETk)Dk − β(LETk)D2k) is the
10% cell survival fraction. The dependence of TCPk on
LET and dose comes from the average value of LET and
dose in the voxel, LETk and Dk. Hence TCP over the
entire volume of the tumor covered by a single scanning
proton beam can be calculated by an integration over
the voxels under radiation. Considering Poisson model
for TCP where SF << 1 [77], it follows
TCP =
∏
k
TCPk =
∏
k
(1− SFk)Nk (52)
≈
∏
k
e−Nk×SFk = e−
∑
k Nk×SFk .
The above summation can simply change to integration
over the corresponding target volume, V
− ln(TCP)
Nv
=
∫
V
d~r
Ωv
e−α(LET~r)D−β(LET~r)D
2
, (53)
where Nv is the average number of cells in a single voxel
with volume Ωv. The TCP calculated by Eq. (53), de-
pends only on dose as the dependence over lineal-energy
and LET has been integrated out.
We now turn to present an estimate on TCP for a
tumor consists of H460 NSCLC cells where the depen-
dence of SF on dose and LET measured experimentally
in our group and fitted by 3D global fitting method by
the present authors. Depends on the location of voxel
in beam, TCPk changes from high doses to low doses
as LET increases. As shown in Figure 9, TCP does not
changes significantly with LET up to an LET value of
LETd = 5.1 keV/µm, which corresponds to a depth prox-
imal to the Bragg peak. Within this range of LETs, all
TCP curves coincide on the top each other. Close and
beyond the Bragg peak we observe a drastic change in
TCP, where increasing LET lowers radiation dose with a
specific TCP (e.g., TCPD = 50%) abruptly.
D. Cell death probability and in-vitro SF
Similar to TCP, we define cell death probability (CDP)
for much smaller number of cells collected and sam-
pled for in-vitro assays. In our latest high-throughput
experiments, 100 cells per well have been seeded and
for each dose-LET combination 16 experimental samples
were replicated. In this series of experiments, the number
of cells per colony after irradiation depends on the dose
and LET. Within each condition there is a distribution
of cells and colonies. We therefore use same concepts and
formulas of TCP to calculate CDP for entire cell popula-
tion death in wells/plates as function of dose and LET.
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FIG. 9: Shown the tumor control probability, TCP, of 106
H460 NSCLC in a typical mm-size volume. As the number of
cells in the volume increases the sigmoid curve shifts to higher
doses.
The results of SF data collected from these experiments
on H460 NSCLC cells is summarized and shown in Fig-
ure 10. In general as we discussed in formulation of the
complexity in cell damage in the preceding sections, the
more complex/thorough damage should in theory result
in a longer delay/cell cycle arrest and thus less cells in
colonies which managed to eventually repair the damage
to go on to form a viable colony. Essentially, the colony
morphology distribution appears to become more hetero-
geneous/broad with increasing damage.
A hallmark of these experiments is systematic eleva-
tion in cell-death with increases in LET. In particular,
the maximum measured doses that lead to entire cell
death in a well in higher LET’s, corresponding to last
circles in Figure 10(a) where SF curves are terminated,
are appeared in lower values. For example the entire cell
population in a well exposed by 80 MeV proton beam
with LET = 19keV/µm, did not survive beyond a dose
of D = 1.6 Gy. In Figure 10(a), this point corresponds
to the last circular point in the first curve from left hand
side.
This observation has raised questions on computation
of the detection limits and possibly saturations in cell
death around empirically observed maximum doses and
if such calculation would be useful in providing rough es-
timates on TCP in larger and denser population of cells
such as in tumors, assuming similar in-vivo biological
conditions as in in-vitro biological endpoints.
Interestingly enough, the three-dimensional global fit-
ting integrated into SF and CDP calculation shows oc-
currence of a saturation around specific doses and LET’s.
These points match with a series of maximum doses given
by specific LET’s reported experimentally, and clearly
visible in Figure 10. Similar to TCP calculation, we con-
sider irradiation of cells by 80 MeV scanning beam of
protons delivered in a single fraction, and use a linear-
FIG. 10: Shown (a) experimental (circles) fitted by three-
dimensional global fitting (red bold lines) of cell survival frac-
tion (SF) and (b) the cell death probability (CDP) of 100
H460 NSCLC used experimentally to measure SF in a 12
wells-plate as a function of dose and LET, irradiated by a
single fraction of scanning proton with approximate nominal
energy of 80 MeV. The end points in SF where the radia-
tion dose is highest, are indicated by arrows in (a), coincide
with the onset of CDP sigmoid turning points. A sharp rise
in sigmoid justifies termination in viability of cells seeded in
the well, hence, a drop in their biological responses. With in-
crease in LET, the maximum experimentally achievable doses
in cell viability that terminate SF curves, lowers.
quadratic model to calculate CDP. The numerical values
for α and β were calculated based on a polynomial expan-
sion in three-dimensional global fitting of SF, dose and
LET from the reported experimental data in our group.
In Figure 10(a), the experimental points are shown in
circles and the red solid lines are the result of 3D global
fitting. For each individual LET, there is a maximum
dose at which the data set is terminated, indicating that
the cell survival detection limit has been reached because
of inactivity of majority of the seeded cells. The blue
arrows are depicted in Figure 10(a) to show the series of
maximally achievable doses for each LET. In Figure 10(b)
we show the result of CDP calculation as a function of
dose and LET for a sample of 100 H460 NSCLC, using
same scale of dose as used for x-axis in Figure 10(a). For
17
illustration of the physical picture discussed above, let us
consider our previous example of SF curve corresponding
to LET = 19keV/µm in Figure 10(a) and draw a vertical
line at D = 1.6 Gy, starting from the last circle in the
curve, down to the horizontal axis in Figure 10(b). This
line connects D = 1.6 Gy in Figure 10(a) and (b) and hit
a point in the shoulder of sigmoid in CDP. By repeating
this for the entire LET SF curves, we observe a patter as
discussed here. Hence, the end points in SF where the
radiation dose is highest, coincide with the onset of CDP
sigmoid turning points. Sharp rises in sigmoid resemble
a rapid termination in the measured biological activities
of the seeded cells. Similar to TCP, depicted in Figure 9,
with an increase in LET, the threshold in cell death falls
to lower doses. Comparison with the experimental data
confirms a shift in sigmoid turning points to higher doses
as the number of seeded cells increases.
V. DISCUSSION AND CONCLUSION
The cell survival data reported in Guan et al.[13] show
the measured biologic effects are substantially greater
than in most previous reports. It is characterized by
a non-linear RBE as a function of LET near and beyond
the Bragg peak. The calculated RBE is characterized by
high sensitivity to small variations in LET distal to the
Bragg peak, where a small uncertainty in the position of
the cells may result in significant change in LET.
Extensive efforts in achieving agreement between the
current formulations and approximations of the standard
RBE models including MKM, LEM, and MCDS-RMF re-
sulted in no success where all of these models appeared to
underestimate RBE of the experimental data [13] in high
LET’s [37]. It is therefore crucial to search for appropri-
ate fitting procedures and models to be able to enhance
the quality of the calculated RBE and the interpretation
of the data.
To address these issues, we recently engaged different
approach and fitted SF-dose-LET experimental data us-
ing polynomial expansion of α and β as a function of
LETd [42]. We continued with this computational model,
and in this work (1) introduced a detailed analytical anal-
ysis and developed a mathematical framework and built
upon event-by-event track structure simulations and mi-
crodosimetry and its formalism to analyze and interpret
the biophysical processes relevant to each term in the
polynomial expansion and (2) improved the quality of
the fitting procedure.
In addition to initial DNA damage, chromatin dynam-
ics were incorporated in our model through phenomeno-
logical repair and mis-repair rate equations. We focused
on two major classes of deviations from the standard
RBE models in high LET domains, e.g., in distal edge to
the Bragg peak. These mechanisms are mainly deviation
of energy loss from Poisson distribution in track struc-
tures discussed in Section II A and chromosome aberra-
tions from binary end-joining discussed in Section II C.
We specifically predicted occurrence of continuous transi-
tions in population of chromosome aberration complexi-
ties amongst binary, ternary, quaternary and higher order
combinations as a function of proton LET, a hypothesis
that must be verified experimentally.
We illustrated the contribution from the energy loss
fluctuations renormalizes the LQ biological parameters
α and β to infinite orders in zD and yD. Interplay be-
tween yD and LETd, obtained in this work from Monte
Carlo simulations, makes a bridged between the micro-
scopic models and macroscopic observations and experi-
mental data. In particular we demonstrated a non-linear
dependence between yD and LETd, that emerges around
LETd ≈ 5keV/µm, attributes to a universal non-linearity
in radio-biological index α even if α scales linearly with
yD as predicted in typical radiobiological models.
We furthermore improved our methodology and results
on global fitting algorithm of the biological responses of
cells under exposure of scanning beam of protons, re-
cently presented in Ref. [42] where a linear function of α
on LETd and constant β fitted the experimental data of
two types of NSCLC H460 and H1437 cell lines reported
by Guan et al. [13] in low LETs. In high LET’s, the
deviation from linear LET model appeared to be promi-
nent such that a non-perturbative correction to the linear
model would be essential. Thus analytical model pre-
sented in this work reveals several complex aspects and
non-trivial predictions of such non-linearity, emerging as
LET increases monotonically.
Specific to these experimental data [13], we divided
LET into three domains of low, intermediate and high,
LETd ≤ 5.08keV/µm, 5.08 < LETd < 10.8keV/µm,
and LETd ≥ 10.8keV/µm respectively. In our previ-
ous work [42], we performed fitting of the experimental
data to linear and non-linear functions of LET in low and
high LET domains separately. In this work, we connected
these solutions numerically by incorporating matching of
the low and high LET solutions in intermediate domain
of LETs where no experimental data were reported. This
extra step of matching allows obtaining continuous SF-
dose-LET surfaces and RBE and their higher gradients
for the entire domains of LET. Otherwise, a discontinu-
ity in RBE and/or its higher derivatives would appear as
a numerical artifact in the intermediate region because
of differences in order of polynomials used for fittings in
low and high LETs. To this end, in the present study, we
performed a post processing multivariate regression fit-
ting algorithm [81] as well as a one-dimensional smooth
interpolation [82] and obtained a continuous RBE, α, β
and α/β curves and their higher derivatives. Within a
range of LETs reported in the experiment in Ref. [13],
these parameters grow continuously as LET increases. A
monotonic trend in lethal lesions, α, β and α/β can be
anticipated via a subclass of the target theories, where
α and β represent DNA damage induction by one- and
two-track action of ionizing radiation that leads to cell
inactivation [72,73].
We then applied the fitted results to the standard TCP
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and CDP models and reported theoretical predictions of
these parameters based on the fitting of the experimental
data in Ref. [13]. We compared the rise in CDP, the
onset of the shoulders between plateaus in sigmoid model
of CDP, with in-vitro experimental data and identified
the characteristics of the maximally achievable absorbed
doses as a function of LET beyond which no biological
activity in the wells and plates were observed. We found
a good agreement between model calculation as well as
physical interpretation of the empirical observations.
We now turn to remark on the implications of the pre-
sented TCP results in clinical applications of proton ther-
apy as shown in Figure 8. In particular in low doses where
the induction of the lethal lesions is significantly higher
in high LET’s, consistent with monotonic increase of α/β
as a function of LET. To be more specific, let us consider
a normal tissue or an organ at risk (OAR), located pos-
terior to a tumor, where the beam exits. In an optimized
dose distribution plan, where the scanning spot patterns
cover the entire volume of the target, the Bragg peak dis-
tal edge falls in posterior edge of the target beyond which
the dose drops rapidly. Let us also consider a hypotheti-
cal situation in which proton deposited dose in a normal
tissue to be within a factor of tenth relative to the average
dose in the tumor. In the present clinical setup where the
dose distribution and the dose volume histograms are the
geometrical metrics in evaluating a patient plan, a tenth
of prescribed dose in a normal organ can be considered
within the tissue tolerance. However, if we take into ac-
count the cell toxicities by LET, the dose weighted by
relative lethal lesions as illustrated in Figure 8, substan-
tially changes the predictive outcome since the relative
number of lethal lesions per Gy per cell in such volumes
can be as high as a factor of ten. Moreover because of
monotonic increase of LET and lethal lesions as shown in
Figure 8, the cell toxicity posterior to the tumor would
be significantly different from its anterior side.
In treatment modalities by photon, it is conventional
to avoid OARs and normal tissues at the beam entrance,
anterior to the tumor. Instead, treatment planners may
allow OARs to be in locations at the exit dose to lower
the toxicity. In treatments using scanning beam of pro-
ton, however, if we take the biological responses such as
the ones depicted in Figure 8 into account, we may antic-
ipate a drop in physical dose may cancel out an increase
in cell toxicity, in particular in tissue volumes where the
exit dose drops to approximately to 1/10 of the dose
compare to beam entrance. Beyond these points, the
drop in dose can no longer be compensated by increase
in lethal lesions, hence the net effect of dose times RBE
falls rapidly, unless if the number of secondary particles
would be significantly large because of a particular beam
arrangement.
The above arguments rationalize a need in extend-
ing to generally expected rules in plan evaluation tech-
niques that are currently based on only the physical dose,
e.g., the beam conformity index, dose volume histogram
(DVH) and etc., to include accurately the biological ef-
fects and proton LET’s in TCP and normal tissue compli-
cation probability (NTCP). Clearly a more reliable clini-
cal plan evaluation must rely on convolution of the phys-
ical dose and cell toxicity and biological responses.
Similarly for tumors, it is customary to apply a uni-
form dose distribution in conventional radiation therapy
by photons. However, incorporating LET to the dose in
TCP shows a need in tailoring this approach. In particu-
lar volumes irradiated by high LET protons, the optimal
dose from TCP is expected to be lower compare to vol-
umes irradiated by low LET protons. Hence to achieve a
uniform TCP a non-uniform dose distribution should be
delivered to the target. To this end, we presented a cal-
culation of TCP to account for spatial variation of LET
and prescribed dose in treatments by scanning beam of
protons. Our calculation shows that TCP will be in-
homogeneous if a homogeneous prescribed dose is ap-
plied. Conversely, one may optimize an inhomogeneous
dose distribution in the target to achieve a homogeneous
TCP .
Unlike the prescription dose in treatments by photons
where a homogenous radiation dose is desired, in scan-
ning proton therapy, and in general, particle therapy,
the effect of LET prevents application of a uniform dose
throughout the target volume. This phenomenon knows
as LET-painting has been recently investigated for treat-
ment of tumors with hypoxic conditions [78–80]. For ex-
ample for small targets, such as metastatic brain tumors,
where scanning beam of proton with a single energy can
be used, a given TCP across the target volume requires
prescribing smaller dose toward the exit points to com-
pensate the effect of higher LET’s. In this case, a distri-
bution of beam angles, e.g., a conformal arc, may help
spreading LETs across the edge of the target to achieve
a uniform TCP with application of a uniform deposited
dose.
We finally remark that the complex aspects discussed
above can not be anticipated and captured only by per-
forming an adhoc Taylor and/or power expansion of α
and β as a function of LET, a practical approach only
useful for mathematical fitting of the experimental data.
This clearly justifies a need for developing step by step
derivation of equations and sophisticated algebra as per-
formed in this work. Thus our approach in combining nu-
merical fitting procedure with analytical track structure
provides a systematic path to apply relevant corrections
to the current RBE models to be able to reconcile theory
with the recent experimental data.
An extension of this approach for particles heavier than
protons is currently under investigation and the goal for
such studies is to generate data needed to optimize treat-
ment plans incorporating the variable RBE.
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VI. APPENDIX A: DERIVATION OF DSB
RATE EQUATION
In this Appendix we present the derivation of Eq. (2)
and show dn(t)/dt =
∑∞
n=0(gn − rn)Qn(t), is the
rate equation associated with the master equation,
dQn(t)/dt = gn−1Qn−1−gnQn+rn+1Qn+1−rnQn, where
n(t) =
∑∞
n=0 nQn(t), hence
dn(t)
dt
=
∞∑
n=0
n
dQn(t)
dt
=
∞∑
n=0
n(gn−1Qn−1 − gnQn
+rn+1Qn+1 − rnQn). (54)
At the boundary of Markov chain, n = 0, the series run
over n = −1, as seen in Eq. (54), and sketched in Fig-
ure 2. To resolve this issue, we extend the chain to in-
clude negative n’s, but with probability Q−|n| = 0. Also
note that the DNA initial condition asserts an assump-
tion on post-irradiation repair mechanisms. Because the
DNA-DSB dynamics starts from acute irradiation that
takes place at n = 0, e.g., the state of DNA with zero
DSB, we assume rn=0 = 0. To this end, we simplify
Eq. (54), by splitting the series into
dn(t)
dt
=
dng(t)
dt
+
dnr(t)
dt
, (55)
where
dng(t)
dt
=
∞∑
n=0
n (gn−1Qn−1 − gnQn)
= 0× (g−1Q−1 − g0Q0) + 1× (g0Q0 − g1Q1)
+2× (g1Q1 − g2Q2) + 3× (g2Q2 − g3Q3)
+4× (g3Q3 − g4Q4) + . . .
= g0Q0 + g1(2Q1 −Q1) + g2(3Q2 − 2Q2)
+g3(4Q3 − 3Q3) + . . .
= g0Q0 + g1Q1 + g2Q2 + . . . (56)
and thus
dng(t)
dt
=
∞∑
n=0
gnQn. (57)
Similarly
dnr(t)
dt
=
∞∑
n=0
n (rn+1Qn+1 − rnQn)
= 0× (r1Q1 − r0Q0) + 1× (r2Q2 − r1Q1)
+2× (r3Q3 − r2Q2) + 3× (r4Q4 − r3Q3)
+4× (r5Q5 − r4Q4) + . . .
= −r1Q1 − r2(2Q2 −Q2)− r3(3Q3 − 2Q3)
−r4(4Q4 − 3Q4) + . . .
= −r1Q1 − r2Q2 − r3Q3 + . . . (58)
and thus
dnr(t)
dt
= −
∞∑
n=1
rnQn = −
∞∑
n=0
rnQn. (59)
In the last equation we added r0Q0 to the series as r0 = 0.
Combining Eqs. 55, 57, 59 we end up with derivation of
Eq. (2)
dn(t)
dt
=
∞∑
n=0
(gn − rn)Qn(t). (60)
VII. APPENDIX B: LINEAL ENERGY OR LET
REPRESENTATIONS
In this Appendix, we present our numerical approach
in simulating moments of specific and lineal energies,
LET’s and their spectrum by performing MC sampling
of event by event energy transfers and stepping lengths
in track structures. We begin with numerical construc-
tion of the lineal energy spectral density that used in the
present study and our recent publication, Ref. [42]. Sam-
ples of lineal energies scored by MC in a specific target
volume and sorted in ascending order. A uniform bin size
through the entire range of lineal-energies were defined
and the number of lineal energies in successive intervals,
∆y, were enumerated. Subsequently statistical moments
of specific and lineal energies were calculated.
To this end, in a target volume and/or voxel, labeled
by index, j, we scored the energy transfers and the asso-
ciated stepping track length at point of interaction, i, for
a particle with species, σ, and constructed a random ma-
trix from lineal energy elements yσi,j = (dεσi/dlσi)j . We
subsequently calculated the distribution function using
the following formulation
Sj(y) =
1
Ny,j
∑
σi
δ(y − yσi,j). (61)
S is normalized in each individual voxel such that
1j =
∫ ∞
−∞
dySj(y)
=
∫ ∞
−∞
dy
1
Ny,j
∑
σi
δ(y − yσi,j)
=
1
Ny,j
∑
σi
∫ ∞
−∞
dyδ(y − yσi,j)
=
1
Ny,j
∑
σi
1σi,j . (62)
Here
∑
σi 1σi,j = Ny,j represents number of lineal energy
events. The average value of lineal energy is then given
by
yj =
∫ ∞
−∞
dyySj(y)
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=
∫ ∞
−∞
dyy
1
Ny,j
∑
σ,i
δ(y − yσi,j)
=
1
Ny,j
∑
σ,i
∫ ∞
−∞
dyyδ(y − yσi,j)
=
1
Ny,j
∑
σi
yσi,j . (63)
Here
∑
σi yσi,j is algebraic sum of lineal energies in a
voxel. By repeating the above procedure we can calculate
the higher order statistical moments of lineal energy, as
given below
ynj =
∫ ∞
−∞
dyynSj(y) =
1
Ny,j
∑
σi
ynσi,j , (64)
where n = 1, 2, 3, ....
Alternatively we may calculate a y-averaged LET (or
yD)
yD,j = LETy,j =
(∑
σi
dεσi
dlσi
Yσi
)
j
=
(∑
σi dεσi/dlσi × (dεσi/dlσi)∑
σi dεσi/dlσi
)
j
=
(∑
σ
∫∞
0
dEΦσ(E) y
2
σ(E)∑
σ
∫∞
0
dEΦσ(E) yσ(E)
)
j
, (65)
where
∑
σi →
∑
σ
∫∞
0
dEΦσ(E). Here Φσ(E) is the dif-
ferential particle fluence of species σ with kinetic energy
E and Yσi denotes the spectral density matrix with ele-
ments containing randomly generated lineal-energies
Yσi =
dεσi/dlσi∑
σi dεσi/dlσi
. (66)
Note that Y is a dimensionless distribution function
where S is a histogram that counts number of lineal-
energy per interval ∆y as defined above. We call LETy,j ,
y-averaged LET.
To be consistent with the distribution function used for
calculation of LET, one may define a deposited dose, av-
eraging over the same distribution function. For example
of y-representation of distribution function
Dy,j =
∑
σi
zσiYσi
=
(∑
σi(dεσi/dmj)× (dεσi/dlσi)∑
σi dεσi/dlσi
)
j
, (67)
where dm is element of the mass in voxel jth.
For completeness of our presentation, we briefly dis-
cuss the construction of dose and track averaged LET,
although they were heavily presented in literature (see,
e.g., [51] and the references therein). In calculation of
dose-averaged LET, LETd,j , we use the following spectral
density
Zσi =
dεσi∑
σi dεσi
, (68)
hence
LETd,j =
(∑
σi
dεσi
dlσi
Zσi
)
j
=
(∑
σi dεσi × (dεσi/dlσi)∑
σi dεσi
)
j
=
(∑
σ
∫∞
0
dEΦσ(E) zσ(E)× yσ(E)∑
σ
∫∞
0
dEΦσ(E) zσ(E)
)
j
,(69)
where dεσi → dεσi/dm = zσ(E). Note that dεi/
∑
i dεi
is a normalized distribution function of the energy trans-
fer in a given voxel, hence any dose averaged quantity,
including the deposited dose, in this representation, were
calculated by the following equation
Dd,j =
∑
σi
zσiZσi
=
(∑
σi dεσi × zσi∑
σi dεσi
)
j
=
(∑
σi dεσi × (dεσi/dmj)∑
σi dεσi
)
j
. (70)
The track averaged LET was calculated using the fol-
lowing formulation
LETt,j =
(dl × y)j
(dl)j
=
(∑
σi dεσi∑
σi dlσi
)
j
. (71)
Considering spectral density of the stepping-track length
Xσi =
dlσi∑
σi dlσi
, (72)
we can easily show that LETt,j =
(∑
σi
dεσi
dlσi
Xσi
)
j
. The
calculated dose, consistent with the distribution function
used for track-averaging is simply sum over all energy
transfers,
Dt,j =
∑
σi
zσiXσi
=
(∑
σi dlσi × zσi∑
σi dlσi
)
j
=
(∑
σi dlσi × (dεσi/dmj)∑
σi dlσi
)
j
. (73)
Finally we consider a trivial distribution function
represented by identity, 1σi. In this representation,
Dj =
∑
σi zσi1σi =
∑
σi dεσi/dmj and LETj =(∑
σi
dεσi
dlσi
1σi
)
j
=
∑
σi dεσi/dlσi.
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VIII. APPENDIX C: GEANT4 MONTE CARLO
SIMULATIONS
In Geant4 each pencil proton beams were simulated
by irradiating a cylinder water phantom with 20 cm ra-
dius and 40 cm length. The mean deposited energies dε
and (dε)2, the mean track length dl were scored within
a linear array of voxels with 0.5 mm thickness. There-
fore y1D = (dε)2/dε/dl as well as other types of LET’s
were calculated. The number of primary protons and the
number of interactions per track were saved, in the same
volume. Then, the energy deposition, the track length,
the number of primary proton and the number of interac-
tions were accumulated, in each cell. All simulations used
106 protons with a cut-off of 0.01 mm, where in Geant4,
any particle with energy below the cut-off value assumed
to not produce secondary particles anymore, and lose en-
ergy by the continuous slowing down approximation. All
simulation results presented used the QGSP-BIC-EMY
physics list. We used Gaussian proton energy spectrums
with very small FWHM (0.18 MeV). Because of small
divergence the simulated beam is mono-energetic.
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